GlassScriptPhysician profile
Amanda Meredith Saxon
NPI 1447740741
$3,474.21
in general payments reported to CMS, 2019-2025
16 companies · $482 in 2025
The $482 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $925 · 2022: $381 · 2023: $818 · 2024: $867 · 2025: $482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,927 · Travel and Lodging: $241.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,926.55 |
| Travel and Lodging | $240.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $516.31 | 2021-2022 | |
| Medtronic, INC. | $393.20 | 2023-2024 | Azure Xt Dr Mri Surescan |
| Astrazeneca Pharmaceuticals LP | $380.74 | 2021-2024 | Farxiga |
| Novartis Pharmaceuticals Corporation | $335.48 | 2021-2025 | |
| Amgen INC. | $304.07 | 2021-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $299.28 | 2022-2025 | Camzyos, Eliquis |
| Cvrx, INC. | $228.94 | 2024 | Barostim Neo System |
| Merck Sharp & Dohme LLC | $200.70 | 2023 | Verquvo |
| Vital Connect, INC | $161.06 | 2023 | Vitalpatch Rtm |
| Pfizer INC. | $151.47 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $143.70 | 2021-2023 | Jardiance |
| Impulse Dynamics (USA) INC. | $142.78 | 2024 | Optimizer |
| Scpharmaceuticals INC. | $110.67 | 2024 | |
| Recor Medical INC | $49.23 | 2025 | Paradise Ultrasound Renal Denervation System |
| Bridgebio Pharma, INC. | $40.05 | 2025 | Attruby |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $16.53 | 2024 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Saxon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.